MESALAZINE RELEASE FROM A PH-DEPENDENT FORMULATION - EFFECT OF CONCURRENT OMEPRAZOLE ADMINISTRATION

被引:2
|
作者
HUSSAIN, F [1 ]
TRUDGILL, N [1 ]
RILEY, S [1 ]
机构
[1] NO GEN HOSP,DEPT GASTROENTEROL,SHEFFIELD S5 7AU,S YORKSHIRE,ENGLAND
关键词
D O I
10.1016/0016-5085(95)27668-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A840 / A840
页数:1
相关论文
共 50 条
  • [1] Mesalazine release from a pH dependent formulation: effects of omeprazole and lactulose co-administration
    Hussain, FN
    Ajjan, RA
    Moustafa, M
    Weir, NW
    Riley, SA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (02) : 173 - 175
  • [2] Efficacy of switching to pH-dependent release formulation of mesalazine at 3.6 g/day from time-dependent release formulation of mesalazine at 4.0 g/day in patients with Ulcerative Colitis
    Motoya, S.
    Tanaka, H.
    Miyakawa, M.
    Sakemi, R.
    Nasuno, M.
    Imamura, A.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S319 - S320
  • [3] Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration
    Kawashima, Kousaku
    Ishihara, Shunji
    Yuki, Takafumi
    Onishi, Koji
    Kushiyama, Yoshinori
    Fujishiro, Hirofumi
    Miyaoka, Youichi
    Yuki, Mika
    Komazawa, Yoshinori
    Tanimura, Takashi
    Sonoyama, Hiroki
    Tada, Yasumasa
    Kusunoki, Ryusaku
    Oka, Akihiko
    Fukuba, Nobuhiko
    Oshima, Naoki
    Moriyama, Ichiro
    Kinoshita, Yoshikazu
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [4] Efficacy of the pH-dependent release formulation of mesalamine in patients with ulcerative colitis
    Tanaka, Hiroki
    Yamashita, Masaki
    Nasuno, Masanao
    Ishii, Manabu
    Motoya, Satoshi
    Imamura, Akimichi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 133 - 134
  • [5] PH-DEPENDENT SOLUBILITY AND DISSOLUTION OF BUPIVACAINE AND ITS RELEVANCE TO THE FORMULATION OF A CONTROLLED RELEASE SYSTEM
    SHAH, JC
    MANIAR, M
    JOURNAL OF CONTROLLED RELEASE, 1993, 23 (03) : 261 - 270
  • [6] PH-DEPENDENT RELEASE OF EDRF FROM RABBIT AORTIC ENDOTHELIUM
    DEMBINSKAKIEC, A
    ZMUDA, A
    GRYGLEWSKI, RJ
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1990, 42 (03): : 265 - 274
  • [7] pH-Dependent Anticancer Drug Release from Silk Nanoparticles
    Seib, F. Philipp
    Jones, Gregory T.
    Rnjak-Kovacina, Jelena
    Lin, Yinan
    Kaplan, David L.
    ADVANCED HEALTHCARE MATERIALS, 2013, 2 (12) : 1606 - 1611
  • [8] PH-DEPENDENT DRUG RELEASE FROM CERTAIN COMMERCIAL TABLETS
    SUTTON, JE
    LACH, JL
    WAGNER, RS
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (12): : 1323 - 1326
  • [9] PANCREATIC-ENZYMES WITH PH-DEPENDENT RELEASE
    BAUMER, P
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1987, 23 (07): : 375 - 387
  • [10] A thermosensitive vaginal gel formulation with HPγCD for the pH-dependent release and solubilization of amphotericin B
    Kim, Ye-Tae
    Shin, Baek-Ki
    Garripelli, Vivek Kumar
    Kim, Jin-Ki
    Davaa, Enkhzaya
    Jo, Seongbong
    Park, Jeong-Sook
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 41 (02) : 399 - 406